Identification of an HLA-A*11:01-restricted Neoepitope of Mutant PIK3CA and Its Specific T Cell Receptors for Cancer Immunotherapy Targeting Hotspot Driver Mutations
CANCER IMMUNOLOGY IMMUNOTHERAPY(2024)
Key words
PIK3CA,Engineering TCR-T,Neoantigen,HLA-A*11:01,Anti-tumor immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined